1 / 13

IMPACT OF AN INTERVENTION PROGRAM FOR THE TREATMENT OF MALARIA IN CHILDREN IN PAPUA NEW GUINEA

IMPACT OF AN INTERVENTION PROGRAM FOR THE TREATMENT OF MALARIA IN CHILDREN IN PAPUA NEW GUINEA. V.Bruce Sunderland Isaac Joshua and Phillip Passmore School of Pharmacy Curtin University of Technology Kent Street Bentley Western Australia 6102. INTRODUCTION. Malaria is a significant disease

towles
Download Presentation

IMPACT OF AN INTERVENTION PROGRAM FOR THE TREATMENT OF MALARIA IN CHILDREN IN PAPUA NEW GUINEA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IMPACT OF AN INTERVENTION PROGRAM FOR THE TREATMENT OF MALARIA IN CHILDREN IN PAPUA NEW GUINEA V.Bruce Sunderland Isaac Joshua and Phillip Passmore School of Pharmacy Curtin University of Technology Kent Street Bentley Western Australia 6102

  2. INTRODUCTION • Malaria is a significant disease • Few studies have evaluated patient understanding of antimalarial medication • A Study in China has shown improved understanding of antimalarials following blister packaging and provision of written instruction

  3. AIMS • Evaluate the impact of an intervention program on patient carers on the understanding of antimalarial drugs in children for uncomplicated malaria. • Evaluate the level of rational use of medication for uncomplicated malaria in children

  4. METHODS • Pre-post intervention with control group • Prescribing was reported • Patients completed questionnaires on past and present medications and compliance. Advise treatment outcome • Intervention: - provision of labelled directions - completion of treatment - return to clinic to advise treatment outcome • Statistics Pre-post differences using Chi-Squared, Kruskal-Wallis, Fisher’s Exact or Student’s t-tests • Standard Treatment Guidelines

  5. RESULTS Table 1 Patient demographics at the clinic pre-post and control pre-post groups

  6. Table 2: LEVELS OF APPROPRIATE PRESCRIBING IN ACCORDANCE WITH THE PNG PRESCRIBING GUIDELINES P-value from Fisher’s Exact Test

  7. Table 3 PATIENT/CARER UNDERSTANDING OF • USE OF THE MEDICINE

  8. Table 3 (b) DOSAGE OF THE MEDICINE

  9. Table 3 (c) FREQUENCY OF DOSAGE

  10. Table 3 (d) DURATION OF TREATMENT

  11. Table 4 PATIENT CARERS RESPONSES TO ASPECTS OF KNOWLEDGE ABOUT MEDICINES P-value from Kruskal-Wallis Test

  12. Table 5 FOLLOW UP DATA COMPARING CONTROL PRE-POST AND CLINIC PRE-POST P-value from Fisher’s Exact Test

  13. CONCLUSIONS • Targeted intervention had no impact on basic understanding of medication administration • Significant understanding of issues related to compliance • Significant improvement in patient outcomes • Improved labelling and information on what procedures to follow if a dose is vomited. • Provision of liquid medicines should be considered.

More Related